Home Tags Bill and Melinda Gates Foundation.

Tag: Bill and Melinda Gates Foundation.

A revolution in nanotech helps create a new vaccine delivery system that could literally...

The Nanopatch, a revolutionary new needle-free device for delivering vaccines, has won a $15 million capital injection (pun intended), but also was an award winner at World Vaccine Congress. After eight years of research, the Nanopatch looks set to revolutionise vaccination delivery forever.

Queensland biotech startup Vaxxas gets $15 million from venture funds

Vaxxas Pty. Ltd. has won a $15 million investment from venture groups led by OneVentures. Other investors include Brandon Capital Partners, the Medical Research Commercialisation Fund and U.S.-based HealthCare Ventures. Vaxxas is the first Queensland company to be funded under the Bio Capital Fund, which has swelled to nearly $250 million, established last year with the help of Health Care Ventures and Eli Lilly, among others. The investment was negotiated in the main by UniQuest Pty Limited, the University of Queensland’s main commercialisation company.
Subscribe to the Newsletter Over 30K subscribers

FREE BUSINESS TOOLS

Strategic Alliances with Simone Novello [FREE INFOGRAPHIC]

Have you heard the often touted claim that the average lifespan of a business is two years? Have you ever wondered why that is? Often, it’s because, in the rush and intensity of starting up, business owners get caught up in day-to-day op-erations and overlook fast growth opportunities, like strategic partnerships. In this FREE INFOGRAPHIC, Simone Novello helps to answer your three most common questions about how to harness the power of... FRIENDS WITH BENEFITS.

FREE BUSINESS TOOL

The Alchemy of Negotiation with Matt Lohmeyer [FREE REPORT]

Negotiation is part and parcel of everyday life. Despite this, the idea of honing our negotiating skills doesn’t go down well with most of us. We fear that we’ll end up being manipulative, exploitative, scheming. To help us break the chains of this retrogressive mentality, we have Matt Lohmeyer. He has worked as a professional negotiator in various fields for over eight years and before that, negotiated deals with biotech pharmaceutical and chemical companies. In short, he’s an Alchemist in the Art of Negotiation.

INFOGRAPHICS

New Zealand’s Xero eyes US IPO, further disruption as subscribers increase...

Xero recently held its annual meeting in Wellington, during which the company revealed some interesting details about its future. As has been widely suspected, the...

OPINIONS & ADVICE